tiprankstipranks
pc:aersk

Aerska

Aerska is a biotechnology company focused on developing RNA interference (RNAi) medicines to treat neurological diseases. Leveraging its proprietary antibody-oligo conjugate (AOC) platform, Aerska aims to overcome the challenges of delivering genetic medicines across the blood-brain barrier. The company is advancing precision medicine strategies targeting genetic forms of Alzheimer's and Parkinson's diseases, with the goal of achieving durable gene silencing in the central nervous system (CNS). Headquartered in Dublin with research operations in London, Aerska is at the forefront of CNS therapeutics innovation.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$21M
Total Amount Raised$21M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$21M
Latest Funding Amount$21M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 08, 2025
Seed Round
$21.00M

Investors

Investor Name
Funding Round
Seed Round
Seed Round
Seed Round
Seed Round
Seed Round
Seed Round
Seed Round
Seed Round

Related News and Analysis